Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Sehrt

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2011
Editorial. Approaches to personalized medicine in oncology--the 9th Annual Meeting of CESAR in GreifswaldChristoph Ritter, Daniel Sehrt, Ulrich Jaehde
International Journal of Clinical Pharmacology and Therapeutics|January 10, 2014
Annual meeting of CESAR in Tuebingen, Germany June 27-29, 2013Joachim von Pawel, Matthias Schwab, Daniel Sehrt
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2012
The 10th annual meeting of CESAR in Essen June 28 - 30, 2012, GermanyUlrich Jaehde, Ralf Hilger, Thomas Gauler, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 14, 2015
EditorialUlrich Jaehde, Gerd Bendas, Daniel Sehrt, et al.
Pharmacogenomics|May 24, 2011
Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogeneticsDaniel Sehrt, Ingolf Meineke, Mladen Tzvetkov, et al.
Current Pharmaceutical Design|September 25, 2018
The Circadian PER2 Enhancer Nobiletin Reverses the Deleterious Effects of Midazolam in Myocardial Ischemia and Reperfusion InjuryYoshimasa Oyama, Colleen Marie Bartman, Jennifer Gile, et al.
Pharmacogenomics|March 19, 2010
Amelogenin-based sex identification as a strategy to control the identity of DNA samples in genetic association studiesMladen Vassilev Tzvetkov, Ingolf Meineke, Daniel Sehrt, et al.
European Journal of Clinical Pharmacology|February 2, 2006
Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteersStefan Viktor Vormfelde, Daniel Sehrt, Daniela Bolte, et al.
Journal of Psychiatric Research|November 30, 2005
Anxiety- and novelty seeking-related personality traits and serotonin transporter gene polymorphismsStefan Viktor Vormfelde, Imke Hoell, Mladen Tzvetkov, et al.
Genome Medicine|November 10, 2016
Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transportersJohannes Matthaei, Mladen V Tzvetkov, Valerie Gal, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2011
Editorial. Approaches to personalized medicine in oncology--the 9th Annual Meeting of CESAR in GreifswaldChristoph Ritter, Daniel Sehrt, Ulrich Jaehde
International Journal of Clinical Pharmacology and Therapeutics|January 10, 2014
Annual meeting of CESAR in Tuebingen, Germany June 27-29, 2013Joachim von Pawel, Matthias Schwab, Daniel Sehrt
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2012
The 10th annual meeting of CESAR in Essen June 28 - 30, 2012, GermanyUlrich Jaehde, Ralf Hilger, Thomas Gauler, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 14, 2015
EditorialUlrich Jaehde, Gerd Bendas, Daniel Sehrt, et al.
Pharmacogenomics|May 24, 2011
Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogeneticsDaniel Sehrt, Ingolf Meineke, Mladen Tzvetkov, et al.
Current Pharmaceutical Design|September 25, 2018
The Circadian PER2 Enhancer Nobiletin Reverses the Deleterious Effects of Midazolam in Myocardial Ischemia and Reperfusion InjuryYoshimasa Oyama, Colleen Marie Bartman, Jennifer Gile, et al.
Pharmacogenomics|March 19, 2010
Amelogenin-based sex identification as a strategy to control the identity of DNA samples in genetic association studiesMladen Vassilev Tzvetkov, Ingolf Meineke, Daniel Sehrt, et al.
European Journal of Clinical Pharmacology|February 2, 2006
Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteersStefan Viktor Vormfelde, Daniel Sehrt, Daniela Bolte, et al.
Journal of Psychiatric Research|November 30, 2005
Anxiety- and novelty seeking-related personality traits and serotonin transporter gene polymorphismsStefan Viktor Vormfelde, Imke Hoell, Mladen Tzvetkov, et al.
Genome Medicine|November 10, 2016
Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transportersJohannes Matthaei, Mladen V Tzvetkov, Valerie Gal, et al.
Pageof 2